Zantac Science Day Presentations About Heartburn Drug Cancer Risks Underway in MDL
Parties involved in litigation over the cancer risks of the heartburn drug Zantac will take part in a Zantac Science Day today and tomorrow in federal court.
Tag Archives: GlaxoSmithKline
-
-
Zantac Cancer Lawsuits To Be Selected For Bellwether Trial Pool
A pool of 200 randomly selected Zantac cancer claims will form the initial discovery pool, from which the first bellwether cases will be selected.
-
Information About Link Between Zantac and Cancers Caused By NDMA To Be Presented During “Science Day” in MDL
A federal judge has called for a "Science Day" to help explain to the Court the scientific concepts behind Zantac, NDMA and the alleged health risks which led to the…
-
Zantac Lawyers to Meet With MDL Judge To Discuss Bellwether Selection Plan
Parties involved in Zantac cancer litigation will meet next week to discuss plans for selecting potential bellwether test cases to go before juries.
-
Class Action Claims to Monitor For Zantac Cancer Diagnosis Cleared To Proceed
A federal judge has ruled Zantac class action lawsuits calling for defendants to pay for the costs of medical monitoring for potential cancer, and to be held responsible for consumers'…
-
Zantac MDL Judge To Consider Motion to Dismiss Amended Medical Monitoring Class Action
A federal judge will hear arguments early next month on whether class action lawsuits calling for the makers of Zantac to pay for medical monitoring for consumers who may now…
-
Zantac Lawsuits Against GSK, Pfizer and Other Brand Drug Makers Survive Motions to Dimsiss
A federal judge has cleared the way for Zantac cancer lawsuits to proceed after rejecting an effort by defendants to have all the claims against them dismissed.
-
Birth Defect Lawsuits Over Zofran Dismissed After Summary Judgment Granted on Federal Preemption
A federal judge has ruled in favor of GlaxoSmithKline, saying Zofran birth defect lawsuits are preempted by federal law due to the FDA's refusal to update the label warnings.
-
Motions to Dismiss Zantac Recall Lawsuits Are Being Considered By Court During Hearing This Week
A federal judge is prepared to hear arguments over whether Zantac lawsuits filed over NDMA contamination and cancer claims can move forward on June 3 and 4.
-
Following Zantac Recalls, Drug Maker Deleted Emails In Violation of Preservation Orders
Plaintiffs say Zantac manufacturers have destroyed evidence and intentionally delayed the discovery process for ongoing federal litigation in violation of court orders.